Form 4 for CNMD CONMED Corp
Accepted 2021-11-02 00:00:00 ET · period of report 2021-10-29 · accession 0001127602-21-028140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-02 | 2021-10-29 | CNMD | Beyer Pat | Pres Int'l, Gbl Ortho | M - OptEx | $45.34 | +106.0K | 63.1K | New | +$4.81M |
| DM | 2021-11-02 | 2021-10-29 | CNMD | Beyer Pat | Pres Int'l, Gbl Ortho | S - Sale+OE | $145.40 | -25.3K | 30.3K | -45% | -$3.68M |
| DM | 2021-11-02 | 2021-10-29 | CNMD | Beyer Pat | Pres Int'l, Gbl Ortho | F - Tax | $145.49 | -63.3K | 33.1K | -66% | -$9.21M |
| DM | 2021-11-02 | 2021-10-29 | CNMD | Beyer Pat | Pres Int'l, Gbl Ortho | M - OptEx | $0.00 | -106.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-29 | M | A | 50,700 | $51.30 | 58,507 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-29 | S | D | 5,589 | $146.14 | 7,807 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2021-10-29 | F | D | 33,253 | $146.28 | 25,254 | D | — | — | |
| 4 | Common | Common Stock | 2021-10-29 | S | D | 16,904 | $145.31 | 13,396 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 5 | Common | Common Stock | 2021-10-29 | M | A | 55,300 | $39.87 | 63,107 | D | — | — | |
| 6 | Common | Common Stock | 2021-10-29 | F | D | 30,018 | $144.62 | 33,089 | D | — | — | |
| 7 | Common | Common Stock | 2021-10-29 | S | D | 2,789 | $144.50 | 30,300 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Derivative | Options To Purchase Common Stock | 2021-10-29 | M | D | 55,300 | $0.00 | 0 | D | $39.87 · — to 2026-03-01 | 55,300 Common Stock | (F4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 9 | Derivative | Sars (Stock Appreciation Rights) | 2021-10-29 | M | D | 50,700 | $0.00 | 0 | D | $51.30 · — to 2025-02-27 | 50,700 Common Stock | (F5) The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period. |